← All indications
Foot Ulcer
Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.
Subtype terms (1)
More specific conditions that are subtypes of Foot Ulcer in the MeSH hierarchy.
- Diabetic Foot
182 drugs (72 approved, 110 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (5)
Phase 3 trials (2)
Phase 2 trials (3)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (24)
- Smith & Nephew
- Merck
- Schülke & Mayr GmbH
- Healthpoint
- Milton S. Hershey Medical Center
- Xinqiao Hospital of Chongqing
- University of Pittsburgh
- Georgetown University
- Jawaharlal Nehru Medical College
- Postgraduate Institute of Medical Education and Research
- University of Hamburg
- University of Messina
- University of North Dakota
- All India Institute of Medical Sciences
- Pennsylvania State University
- Associated Foot & Ankle Specialists
- Amrita Institute of Medical Sciences
- Institute of Post Graduate Medical Education & Research
- Mastelli srl, via Bussana Vecchia, Sanremo, Italy
- P.D. Hinduja Hospital and Medical Research Centre, Mumbai
- Integra LifeSciences Corporation
- University of Campania Luigi Vanvitelli
- University of Geneva
- People's Liberation Army of China
Organization Involved with Phase 3 Indications (65)
- Adocia
- United Therapeutics
- Pfizer
- Osiris Therapeutics
- Anterogen Co., Ltd.
- Biotec Pharmacon ASA
- Dipexium Pharmaceuticals, Inc.
- European Egyptian Pharmaceutical Industries
- FirstString Research, Inc.
- Genaera Corporation
- INC Research
- Innocoll
- MacroChem Corporation
- Microbio Co Ltd
- Novalead Pharma Private Limited
- Olympus Biotech Corporation
- Tissue Tech Inc.
- Virchow Group
- Daewoong Pharmaceutical Co. LTD.
- Derma Sciences, Inc.
- Rovi Pharmaceuticals Laboratories
- Fundación Cardiovascular de Colombia
- Ajou University
- Alexandria University
- Cairo University
- Centro Nazionale Sangue
- Chang Gung University
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Korea University
- Mashhad University of Medical Sciences
- +35 more
Organization Involved with Phase 2 Indications (66)
- Celgene
- Cato Research
- Genentech
- CoMentis
- Bridge BioResearch Ltd.
- Catalysis SL
- Charsire Biotechnology Corp.
- Chiesi
- Energenesis Biomedical Co., Ltd.
- FGK Clinical Research GmbH
- HealOr
- Izun Pharma Ltd
- Karyopharm Therapeutics Inc
- Lynch Biologics LLC
- OXO Chemie
- NanoSHIFT LLC
- Ology Bioservices
- Pherecydes Pharma
- Remedor Biomed Ltd
- Royer Biomedical, Inc.
- Skingenix, Inc.
- Transwell Biotech Co., Ltd.
- A2 Healthcare Taiwan Corporation
- Kuros Biosurgery AG
- National Institutes of Health (NIH)
- University of Arizona
- Centre Hospitalier Universitaire de Nīmes
- Kaohsiung Medical University
- Medical University of Warsaw
- Royan Institute
- +36 more
Organization Involved with Phase 1 Indications (20)
- Roche
- Genzyme
- GlaxoSmithKline
- Mallinckrodt
- Tissue Repair Company
- Phage Pharmaceuticals, Inc.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- National Cheng Kung University
- New York University
- Assiut University
- Capital Medical University
- University of Colorado, Denver
- Leiden University
- Hebrew University
- Bezmialem University
- Spartanburg Regional Healthcare System
- Stratatech Corporation
- Blue Blood Biotech Corp.
- Steno Diabetes Center Copenhagen
Organization Involved with Other Experimental Indications (21)
- MiMedx Group, Inc.
- Sonescence, Inc.
- University of Manitoba
- Allegiance Health
- Mansoura University
- Northwestern University
- Services Hospital, Lahore
- Sutter Health
- Universidad Complutense de Madrid
- Tel Aviv University
- University of Copenhagen
- King Hamad University
- Sonoma West Medical Center
- Stellenbosch University
- Washington University in St. Louis
- Heritage Medical Research Institute
- Cook Medical
- Solsys Medical
- Udayana University
- ACell Inc.
- University of Las Palmas de Gran Canaria